The present invention relates generally to medical imaging. More particularly the present invention relates to CEST magnetic resonance imaging.
Chemical Exchange Saturation Transfer (CEST) imaging has been attracting attention due to its unique characteristics: 1) the ability to detect signals from low concentration species based on the highly selective saturation of rapidly exchanging spins and 2) the capability of detecting changes in environmental parameters in vivo including: pH, temperature and ion concentration. There have been a number of pre-clinical and now also clinical applications which involve either the detection of administered or endogenous CEST agents. A theme of many of these studies involves applying CEST imaging to cancer for characterization of tumor vasculature, metabolism, extracellular pH and nanocarrier uptake.
In order to detect CEST contrast, it is common practice to increment the frequency of a saturation pulse across a range of frequencies. The simple and most common method to detect and quantify CEST contrast is by calculating the asymmetry in the magnetization transfer ratio (MTRasym) at the frequency of the exchangeable protons (Δω):
which is the subtraction of the two water signal intensities with saturation pulse at +Δω and −Δω with respect to water, S(+Δω) and S(−Δω), normalized by the signal without saturation (S0), or by S(−Δω) to amplify the dynamic range. Tumors and strokes display contrast on MTRasym maps at saturation offsets between 1-3.5 ppm from water, an effect that has been connected to the amide protons of extra soluble peptides/proteins found in brain tumors which resonate around 3.5 ppm from water, or changes in pH and has been termed Amide Proton Transfer (APT). The amount of APT signal produced by brain tumors was shown to correlate with histopathological grade in patients on clinical 3T scanners, and was also shown to be a marker that could differentiate tumor recurrence from radiation necrosis. There are also attempts to monitor tumor response to HIFU and chemotherapy.
Although CEST imaging has shown great potential for oncological imaging, there are obstacles towards widespread application, including the low Contrast-Noise-Ratio (CNR) of the images, sensitivity to field inhomogeneities, and susceptibility to interference from other sources of contrast. In addition, collection of CEST images can be quite time-consuming. A typical scheme for a CEST pulse sequence is shown in
Because of the challenges mentioned above, new methods are needed which improve the specificity of CEST measurements or reduce image acquisition times. Recently several acquisition methods have been developed including methods to suppress MTC such as SAFARI, Two-frequency and VDMP and sequences for extracting components of exchange contrast e.g. CERT, Spin-Lock and FLEX. There are also sequences for accelerating CEST data acquisition, such as using RARE or FLASH, CEST-FISP, steady-state methods for fast 3D brain imaging of APT and recently methods based on gradients applied during saturation can push the speed of Z-spectrum collection to single-shot. Gradient-encoded offset methods are intriguing, but currently only have been demonstrated in vitro and might be very challenging in vivo due to inhomogeneous distribution of contrast.
One proposed strategy for improving CEST image specificity acquires multiple STw images with different saturation lengths (tsat) to add another dimension of information describing the decay in the water signal. In simple phantoms (CEST agent in water/PBS), the changes in MTRasym as a function of saturation length (tsat) can be used to measure exchange rates (Ksw), otherwise known as QUEST. In vivo, this Length and Offset VARied Saturation (LOVARS) data can be studied to separate tumor pixels from control brain tissue through the different tsat-dependence of MTRasym values. This data can discriminate the different levels of interference from MTC, DS and NOE, through collecting tsat-dependence information and increase CNR and the specificity of CEST imaging. Unfortunately, it is not practical to acquire images with multiple tsat's and also with multiple saturation offsets (Z-spectra) due to long scan times, although both of them are useful for improving the CEST imaging.
It would therefore be advantageous to provide an efficient and effective form of CEST magnetic resonance imaging, which enables multiple readouts of water signal during the long procedure of Sat. Prep., instead of placing a single readout after one long preparation as conventional CEST studies have been performed.
The foregoing needs are met, to a great extent, by the present invention, wherein in one aspect a method for magnetic resonance imaging of a subject includes generating a magnetization using an magnetic resonance imaging machine. The method includes applying “N” number of iterative modules to achieve multiple readouts. The “N” number of iterative modules each include a saturation preparation component, a readout component, and a flip back component. The method also includes processing the multiple readouts into an image of the subject.
In accordance with an aspect of the present invention, the method includes using N equals approximately 3 to 8 modules and using modules with a length of tsat/N. Alternately, the method includes using modules with a length of approximately 0.3 to 1 second. The method includes using the readout component comprising a low flip angle fast gradient echo readout sequence. The method also includes using a flip angle of α and using a flip back pulse for retaining the magnetization. The method includes defining magnetization as longitudinal magnetization
in the absence of saturated protons. The method includes defining magnetization as longitudinal and transverse magnetization and defining magnetization as
M
N
z,α
=M
N
z,sat·cos α a)
M
N
x,α
=M
N
z,sat·sin α b)
when applying the flip angle component. Additionally, the method includes defining longitudinal magnetization after the Nth module as
The method also includes defining an iterative relationship between modules as
The method includes using a T2 decay term. The method can also be executed using a non-transitory computer readable medium.
The presently disclosed subject matter now will be described more fully hereinafter with reference to the accompanying Drawings, in which some, but not all embodiments of the inventions are shown. Like numbers refer to like elements throughout. The presently disclosed subject matter may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements. Indeed, many modifications and other embodiments of the presently disclosed subject matter set forth herein will come to mind to one skilled in the art to which the presently disclosed subject matter pertains having the benefit of the teachings presented in the foregoing descriptions and the associated Drawings. Therefore, it is to be understood that the presently disclosed subject matter is not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims.
The present invention provides a novel approach for CEST MR imaging, called Multi-echo Length and Offset VARied Saturation (Me-LOVARS) CEST. This method allows efficient collection of additional CEST data without penalty in scan time, which could be useful for enhancing the contrast, increasing the specificity or improving quantification of exchange. As CEST-MRI has shown promise at both the pre-clinical and clinical levels, including for detecting and grading brain tumors and evaluating ischemia, using either endogenous CEST contrast or through administration of CEST contrast agents. This fast and robust imaging method is suitable for accelerating image collection and widening the scope of applications for CEST-MRI.
Further, the present invention includes a hybrid CW-pulsed approach, Multi-echo LOVARS (Me-LOVARS), using fast T1 mapping for collecting multiple images at varied saturation lengths within each TR. This can be used either for correcting contrast maps against MTC, B0, B1 inhomogeneity or for further contrast characterization such as to determine Kex. Method Images were acquired on SCID/NCR mice (n=4) bearing intracranial xenografts derived from human glioblastoma neurospheres (HSR-GBM1A) on a Bruker Biospec 11.7T scanner, with a 72 mm birdcage resonator as transmitter and a surface array coil as receiver. MR parameters were: 3 sat. pulses with Tsat=0.8 s, B1=2 uT, 4 segment EPI with 7.85 ms each, flip angle (α)=25o, TR/TE=5 s/5.27 ms, FOV=16.5×15.5×1 mm. and matrix size=96×64.
An imaging sequence in accordance with the present invention provides that the long saturation pulse is divided into 3-5 blocks of 0.5 s−1 s(n×Tsat, n=1, . . . , 5), in front of low flip-angle fast gradient echo read-outs (here EPI) with a flip-back pulse after the image readout to retain the longitudinal magnetization.
Instead of employing a single long Sat. Prep. module of length tsat (i.e. >1 sec.) before echo readouts, the Me-LOVARS method divides this Sat. Prep. into N=3-8 sub-modules, each with a length of tsat/N (˜0.3 sec.-1 sec.), and in between inserts a low flip-angle (FA=α) fast gradient echo read-out sequence (here EPI), followed by a flip back pulse (FA=−α) for retaining longitudinal magnetization (
Supposing the longitudinal magnetization before the Nth MeLOVARS Module is MNz, based on a simplified two-pool exchange model including a small solute pool and large water pool, the longitudinal magnetization in the absence of back exchange of saturated protons becomes:
the fractional concentration of solute protons, ε is the saturation efficiency, and ksw is the forward solute proton to water exchange rate.
When applying a small flip angle pulse, the longitudinal and transverse magnitizations becomes:
M
N
z,α
=M
N
z,sat·cos αa)
M
N
x,α
=M
N
z,sat·sin αb) [2]
Where MNx,α is the Nth FID signal prior to readout for reconstructing the Nth STw images. After a short Gradient-Echo based readout, the transverse magnetization decays to
Upon application of a flip-back pulse, FA=−α, the longitudinal magnetization after the Nth module is:
As the starting magnetization of the Nth module (MNz) is equal to that at the end of the (N−1)th module MN-1z,−α, an iterative relationship between the successive modules can be achieved:
Combining Eq.4 and Eq.2b, the Nth FID signal readout MNx,α is given by:
Compared to the conventional signal-readout sequence with the same FA:
the Nth module readout of Me-LOVARS has an extra T2*-weighted Decay Factor
which is also a function of the measurement parameters including: N, α, and TE, as well as the local T2*.
Exemplary implementations of the present invention are described herein, in order to further illustrate the present invention. The exemplary implementations are included merely as an example and is not meant to be considered limiting. Any implementation of the present invention on any suitable subject known to or conceivable by one of skill in the art could also be used, and is considered within the scope of this application.
To evaluate the MeLOVARS sequence, a phantom was prepared consisting of four 5 mm NMR tubes, with one filled with 0.01 M phosphate-buffered saline (PBS) as the negative control, and the other three each filled with a CEST agent at a concentration of 25 mM in PBS. The three agents were: 1) D-Glucose (Δω=0.9-1.5 ppm, pH 7.4); 2) Salicylic Acid (Δω=9.3 ppm, pH 7.1); 3) 5-Chloro-2-(methyl-sulfonamido)benzoic acid (Δω=7.2 ppm, pH 7.1) with all agents titrated using NaOH and HCl.
All in vitro MR scans were acquired on a Bruker vertical 750 MHz scanner at a temperature of 310K. A 2-shot EPI readout scheme was used with TR/TE=8 sec.s/5.25 ms, EPI module time=7.05 ms and Matrix Size=32×32. Z-spectra were acquired using a CW saturation pulse with B1=2.4, 3.6, and 4.8 μT and the saturation offset incremented 0.3 ppm for −9.9 ppm->−6.9 ppm, −2.7 ppm->2.7 ppm, and 6.9 ppm->9.9 ppm and 0.6 ppm increment for −6.9->−2.7 ppm and 2.7 ppm->6.9 ppm.
Simulations
To simulate the CEST contrast produced by the MeLOVARS sequence for mice bearing glioblastomas and optimize α and N, the 4-pool bloch equations were numerically solved with the semi-solid pool, the amide pool, the aliphatic pool and the water pool with Δω=0 ppm, 3.6 ppm, −3.6 ppm and 0 ppm respectively. Each module of MeLOVARS was simulated as the pulse-sequence described in
In Vivo Animal Studies
MR images were acquired on SCID/NCR mice (n=4) bearing intracranial xenografts derived from human glioblastoma neurospheres (HSR-GBM1A) on a Bruker Biospec 11.7T scanner, using a 72 mm body coil for transmission and a 4-channel phase-array surface coil for reception. Two sets of MR parameters were used for testing Me-LOVARS (N=3 or 5): N=3 saturation pulse length=0.8 sec.(⅓Tsat), 4 segment EPI (7.85 ms per segment), α=25°, saturation offsets=[±4.8, ±4.2, ±3.9, ±3.6, ±3.3, ±3, ±2.4, ±1.5, ±0.6, ±0.3, 0] ppm or N=5 saturation pulse length=0.5 sec.(⅕Tsat), 6 segment EPI (6.4 ms per segment), α=25°, TR/TE=4 s/4.3 ms, FOV=16.5×15.8×1 mm, matrix size=96×64. B1 was set to 1.2 uT, 2 uT and 3 uT. Conventional CEST images were also acquired using a single 6 segment EPI readout (tsat=2.4 sec) using the same parameters as MeLOVARS. For MeLOVARS, the Z-spectra acquisition time is 8 min 48 sec, plus an additional 80 sec for the WASSR image-set for B0 mapping and corrections, resulting in ˜10 min of scanning.
Post-Processing
All data were processed using custom-written MATLAB scripts. For both phantom and in vivo study, a voxel-by-voxel Z-spectra B0 correction was performed through interpolating the original data to every 0.1 ppm using a piecewise polynomial fitting, with B0 values from WASSR. CEST contrast was quantified by MTRasym=(S(−Δω)−S(+Δω)/S0, S0 is the image with same FA readout without saturation pulse. For glucose with faster exchange (ksw>1 k Hz) and with three Δω's, calculated an average MTRasym of [0.9 ppm, 1.2 ppm, 1.5 ppm], similar to the previous studies. For other agents with a single Δω, MTRasym is only calculated at the peak CEST frequency. To increase the CNR for in vivo mice study, the contrast maps for amide (—NH, APT weighted) and amine (—NH2) freq. were obtained by averaging MTRasym from 3.3 to 3.9 ppm, and from 2.6 to 3 ppm, respectively.
Except for the conventional MTRasym analysis, Principal Component Analysis (PCA) was also applied in processing the STw images of different Tsat at +Δω or −Δωacquired by MeLOAVRS, namely the time-resolved CEST data. As a data-driven multivariate statistic technique, PCA had been used in analyzing the time series data in PET, fMRI, dynamic contrast enhanced (DCE) MRI and optical imaging. And here it is used to extract the independent variations (named Principal Components) among images with multiple Tsat's, supposing one of the biggest variances is due to the build-up of CEST contrast (for the +Δω dataset) or the NOE contrast (for the −Δω dataset).
Results
Simulations
Signal readout of the Nth module in MeLOVARS can be simply estimated by multiplying the conventional single-readout signal with the same length with an extra T2*-weighted term
which is a function of the measurement parameters number of modules (N), FA (α) and TE.
Phantom Experiments
A phantom study based on the simulations described above was also performed to determine whether the MeLOVARS acquisition scheme enables more rapid quantification of exchange rates (Ksw) using the QUEST method, and how the data compares with those collected using a single module. Z-spectra were collected with num. of modules N=8 (from 0.5 s to 4 s with every 0.5 s increment) to fit using numerical simulations, allowing 8× acceleration over the conventional 8 single readouts.
In Vivo Imaging of Mice Brain
MeLOVARS data was also acquired on mice brain bearing glioblastoma, with number of module=5 and each of 0.5 sec. in length, which produces multiple Z-spectra (
As is known, for in vivo CEST imaging, multiple pools are saturated which exchange with H2O, thus the actual measured MTRasym is a combination of CEST, MT, DS and also the NOE from the aliphatic protons with frequency at the other side of water, where the simplified 2-pool model may not be applicable. Using a 4-pool Bloch model, the experimental 5 Z-spectra from MeLOVARS for both tumor (
As an illustration,
The MTRasym contrast values and the CNR of images were quantitatively compared using the conventional method (Conv.) and MeLOVARS (Me.) for this group of mice (n=3), as shown in Table 2. The first 3 rows compare the averaged MTRasym_Tumor, MTRasym_Ctrl and ΔMTRasym of the three mice and their standard deviation, for the cony. method with Tsat=0.5 s, 1 s, 1.5 s, 2 s and 2.5 s and MeLOVARS with Module 1 to Module 5, respectively. As seen, the averaged values of MTRasym
For the Nth module readout in MeLOVARS (or the conventional method with the same corresponding Tsat), CNR was calculated by expanding it using
CNR=MNx,α−Δω−MNx,α+Δω−MNx,α−Δω−MNx,α+Δω=M0,Nx,α·M0,Nx,ασ−Δω2+σ+Δω2=MTRasym·SNR0,N√2
where MTRasym=[MNx,α(+Δω)−MNx,α(−Δω)]/M0,Nx,α and SNR0,N is the Signal-Noise-Ratio for the Nth module without saturation. Thus, supposing there is no changes in the noise level σ, compared to conventional one, the SNR S0 of the Nth module will drop a factor of
as shows the decreasing SNR of Me. from N=1 to N=5 in the 4th row in Table2. However, as the contrast between tumor and control tissue, ΔMTRasym, is slightly higher for MeLOVARS when N>1, the resulting CNR of MeLOVARS is also higher than that of Conv. method with the same Tsat when N>1.
The present invention is directed to a MeLOVARS method proposed for acquisitions of images with multiple saturation length (tsat) without extra time cost, which is readily applied to both phantom and in vivo CEST imaging. A simple analytical guideline of how to choose Number of Modules (N), Flip Angle (α) and TE/T2*, to ensure a small Decay Factor (e.g. DF<10%) compared to the conventional methods with a single module, which is caused by the dephasing processes of the multiple readouts is proposed. For the phantom, 3 CEST agents were used with varying offsets from 0.9 ppm to 9.3 ppm, demonstrating that MeLOVARS could enable fast QUEST acquisition and accurate fitting of Ksw when α<30 deg. at a high field strength (B0=17.6 Tesla). When α>=30, the MeLOVARS contrast start dropping for the larger N's compared to the conventional one with same Tsat, this is presumably because the local small T2* at this ultra-high field. For example, according to the parameter guidance of Eq. [5] and
One big advantage of MeLOVARS is that, it could be readily implemented to in vivo CEST imaging sequences based on gradient-echo readouts (GE or GRE) that have been used at both high field scanners and low field ones. As a proof MeLOVARS for imaging the endogenous APT contrast was applied in mice bearing glioblastoma at a filed strength of 11.7 Tesla, which could generate multiple Z-spectra, MTRasym Spectra and contrast maps with different effective Tsat's. As shown in
It should be noted that the methods described herein can be executed with a program(s) fixed on one or more non-transitory computer readable medium. The non-transitory computer readable medium can be loaded onto a computing device, server, imaging device processor, smartphone, tablet, phablet, or any other suitable device known to or conceivable by one of skill in the art. It should also be noted that herein the steps of the method described can be carried out using a computer, non-transitory computer readable medium, or alternately a computing device, microprocessor, or other computer type device independent of or incorporated with an imaging or signal collection device. The computing device can be integrated with the imaging device for collecting data or can be networked by wire or wirelessly with the imaging device. Indeed, any suitable method of calculation known to or conceivable by one of skill in the art could be used. It should also be noted that while specific equations are detailed herein, variations on these equations can also be derived, and this application includes any such equation known to or conceivable by one of skill in the art. A non-transitory computer readable medium is understood to mean any article of manufacture that can be read by a computer. Such non-transitory computer readable media includes, but is not limited to, magnetic media, such as a floppy disk, flexible disk, hard disk, reel-to-reel tape, cartridge tape, cassette tape or cards, optical media such as CD-ROM, writable compact disc, magneto-optical media in disc, tape or card form, and paper media, such as punched cards and paper tape.
Researchers have also started to investigate the amount of APT contrast produced by other types of tumors including: lung, breast, and prostate cancer. Regarding to the gradient-echo based readout used in MeLOVARS, there could be concerns practically, especially at high field or for body applications. For example, MeLOVARS was validated for in vivo imaging of mice bearing glioblastoma at 11.7 Tesla. And the contrast heterogeneity at the control tissue may appear on the Me-LOVARS maps with N>1 (
The proposed a CEST acquisition method, named Multi-Echo Length and Offset VARied Saturation (Me-LOVARS) rapidly acquires multiple STw images of different effective Tsat, without extra scan time.
For phantoms MeLOVARS collects images with 8 tsat's from 0.5 s to 4 s simultaneously, enabling the measurement of the exchange rates for three CEST agents. For in vivo imaging of mice brain bearing glioblastomas, MeLOVARS enable acquisition of 5 Z-spectra, MTRasym spectra and contrast maps in 8.5 min, with 5 tsat's from 0.5 s to 2.5 s, where in each module the MTRasym difference between tumor and control tissue and the corresponding Contrast-Noise-Ratio (CNR) was shown either higher or comparable than those by conventional method. The MeLOVARS data could be used for fitting the multi-pool exchange model, separating CEST and NOE by analyzing the contrast buildup and improving CNR √N times via image averaging.
In addition, although the present invention has only focused on the endogeneous APT contrast of brain tumor in the manuscript, this method is applicable to many applications either using the endogenous molecules glutamate, creatine, and glycosaminoglycans, or the exogenous compounds.
Although the present invention has been described in connection with preferred embodiments thereof, it will be appreciated by those skilled in the art that additions, deletions, modifications, and substitutions not specifically described may be made without departing from the spirit and scope of the invention as defined in the appended claims.
This application claims the benefit of U.S. Provisional Patent Application No. 61/830,355 filed on Jun. 3, 2013, which is incorporated by reference, herein, in its entirety.
This invention was made with government support under R01 EB015031 and 1R01EB012590 awarded by the National Institutes of Health. The government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2014/040599 | 6/3/2014 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
61830355 | Jun 2013 | US |